ArticleRadiology advances2026
When is patient-specific lung shunt fraction necessary in
Article in Radiology advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Reply to editorial "From Probability to Practice: Demystifying When Lung Shunt Fraction Matters inRadiology advances · 2026Article
- From probability to practice: demystifying when lung shunt fraction matters inRadiology advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung shunt fraction (LSF) derived from macroaggregated albumin (MAA)-based nuclear medicine imaging is a standard component of yttrium-90 selective internal radiation therapy ( Purpose: To propose and evaluate a pretreatment identification method for patient-specific LSF that may influence treatment planning in Methods: MAA SPECT/CT-based LSF (LSF Results: A total of 354 cases were analyzed from 297 patients (92 females and 205 males). Median (interquartile range) age at MAA-SPECT/CT was 69 (63-74). LSF Conclusion: Patient-specific, MAA-based LSF determination may be obviated in most
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.